A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2001
11/08/2001	WO2001083510A1 29 human secreted proteins
11/08/2001	WO2001083508A1 Antisense modulation of zinc finger protein-217 expression
11/08/2001	WO2001083503A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
11/08/2001	WO2001082973A2 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies
11/08/2001	WO2001082970A1 Mixtures of triblock polyesterpolyethylene glycol copolymers
11/08/2001	WO2001082948A2 Uses of tgap7 for the modulation of leucocyte activation
11/08/2001	WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	WO2001082900A1 Non-invasive gene targeting to the brain
11/08/2001	WO2001082780A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
11/08/2001	WO2001082699A1 A gene therapy system and method using alpha-msh and its derivatives
11/08/2001	WO2001032697A3 Virulence genes and proteins from brucella melitensis, and their use
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001032128A3 Human chemokine beta-13
11/08/2001	WO2001030810A3 Relaxase and other vir proteins as targets for treatment of helicobacter pylori infection and as dna transfer system to mammalian cells
11/08/2001	WO2001030383A3 Medicament in order to induce tolerance
11/08/2001	WO2001029068A3 A eag gene encoding for a potassium channel
11/08/2001	WO2001018035A3 Muc-1 derived peptides
11/08/2001	WO2001008707A3 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/08/2001	WO2000076556A9 High dose radionuclide complexes for bone marrow suppression
11/08/2001	WO2000069897A3 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/08/2001	WO2000053775A9 Prevention and treatment of viral infections
11/08/2001	WO2000053745A9 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
11/08/2001	US20010039666 Non-human mammalian model for atherosclerosis and methods for screening agents for use in the treatment of atherosclerosis
11/08/2001	US20010039335 Genetic engineering
11/08/2001	US20010039052 Surface antigen expression allows for identification and selection of genetically modified cells; gene therapy
11/08/2001	US20010039051 Utlizing the Varicella-Zoster virus protein's ability to enter and exit eukaryotic cells for drug or secreting agent delivery
11/08/2001	US20010039046 Genetically engineered adenovirus comprising a genome whose E1 region is deactivated, whose organization is modified and the recombination of which with the genome of the producing line leads to the new viral vectors; gene therapy
11/08/2001	US20010039038 Novel glucosaminidase
11/08/2001	US20010039017 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/08/2001	US20010039016 Measurement, calibration gene expression
11/08/2001	US20010039013 Screening, diagnosis cancer
11/08/2001	US20010038859 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
11/08/2001	US20010038837 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/08/2001	US20010038836 Administering a mammalian stem cells of myeloid origin into a nervous system of the mammal, migrating these cells from injection site to prefered site in a nervous system, engrafting above cells into nervous system of the mammal
11/08/2001	DE10021475A1 New opioid-type receptor-1 gene, OTR1, useful for diagnosis and treatment of OTR1-related diseases
11/08/2001	DE10021474A1 New monoamine receptor-1 gene, MAR1, useful for diagnosis and treatment of MAR1-related diseases
11/08/2001	CA2750984A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2443555A1 Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
11/08/2001	CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	CA2408011A1 Splice-region antisense composition and method
11/08/2001	CA2407959A1 Human wingless-like gene
11/08/2001	CA2407942A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
11/08/2001	CA2407900A1 Methods and compositions for effecting homologous recombination
11/08/2001	CA2407881A1 Vectors for ocular transduction and use thereof for genetic therapy
11/08/2001	CA2407700A1 Compositions and methods for inducing activation of dendritic cells
11/08/2001	CA2407656A1 Myocardial cell proliferation-associated genes
11/08/2001	CA2407604A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	CA2406755A1 A gene therapy system and method using alpha-msh and its derivatives
11/08/2001	CA2406746A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	CA2406743A1 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/08/2001	CA2403901A1 29 human secreted proteins
11/07/2001	EP1152060A1 5T4 tumour-associated antigen for use in tumour immunotherapy
11/07/2001	EP1152058A1 Methods and compositions for effecting homologous recombination
11/07/2001	EP1152056A1 Method for modifying genetic characteristics of an organism
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1152009A1 Novel nucleosides and oligonucleotide analogues
11/07/2001	EP1151141A1 A method of treating anemia
11/07/2001	EP1151124A1 Gene repair involving in vivo excision of targeting dna
11/07/2001	EP1151123A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
11/07/2001	EP1151122A1 Latency-associated regulatory region from herpesvirus saimiri (hvs)
11/07/2001	EP1151113A2 Human peptidases
11/07/2001	EP1151102A1 Glycosylated leptin compositions and related methods
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
11/07/2001	EP1151092A1 Inhibiting formation of atherosclerotic lesions
11/07/2001	EP1151091A1 Improved helper dependent vector system for gene therapy
11/07/2001	EP1151089A1 Catalytic molecules
11/07/2001	EP1151083A1 Nitroreductase enzymes
11/07/2001	EP1151006A1 Human g protein coupled receptor
11/07/2001	EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
11/07/2001	EP1150711A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
11/07/2001	EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
11/07/2001	EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS
11/07/2001	EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
11/07/2001	EP1150705A2 Protection of cells in connection with treatment with chemical agents
11/07/2001	EP1150698A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
11/07/2001	EP1150696A2 Treatment of tumors with genetically engineered herpes virus
11/07/2001	EP1150691A2 Novel antisense inhibition of rad51
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP1150570A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone
11/07/2001	EP1003711B1 Novel lipopolyamines, and the preparation and use thereof
11/07/2001	EP0820526B1 Coding sequences of the human brca1 gene
11/07/2001	EP0689596B1 Stimulation of immune response by viral protein
11/07/2001	CN1321199A Cell lines for propagation of mutated herpes viruses
11/07/2001	CN1321193A RNA virus vector having contact infiltration capability
11/07/2001	CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
11/07/2001	CN1321093A Method to enhance and confine expression of genes
11/06/2001	US6313280 Suppresses brachyury-mediated transcription activation; hybrid screening assays; zinc finger domains; genetic engineering and expression
11/06/2001	US6313277 Breast cancer resistance protein (BCRP) and the DNA which encodes it
11/06/2001	US6313270 DbpB
11/06/2001	US6313269 Tumor necrosis factor related receptor, TR6
11/06/2001	US6313264 Effector proteins of Rapamycin
11/06/2001	US6312957 Genetic modification of primate hemopoietic repopulating stem cells
11/06/2001	US6312949 Cell having exogenous nucleic acid which codes for an amino acid sequence which activates tyrosine hydroxylase expression; treatment of parkinson's disease, manic depression, and schizophrenia
11/06/2001	US6312948 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells
11/06/2001	US6312946 Viable contaminant particle free adenoviruses, their prepartion and use
11/06/2001	US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases

1 ... 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 ... 870